Vaccine could mean fewer smear tests needed 适龄接种 HPV 疫苗可大幅减少患宫颈癌风险
2 years, 8 months ago

Vaccine could mean fewer smear tests needed 适龄接种 HPV 疫苗可大幅减少患宫颈癌风险

China Daily  

媒体英语 Vaccine could mean fewer smear tests needed 适龄接种 HPV 疫苗可大幅减少患宫颈癌风险 Play audio file 一位顶尖科学家表示，接种 HPV 疫苗的女性可能一生只需做一次刮片检查，就可以帮助预防宫颈癌。目前在英国，适龄女性每三到五年会被邀请进行一次筛查。 Nearly all cases of cervical cancer are caused by human papillomaviruses, known as HPV. 2008年，随着 HPV 疫苗（在英国）的引入，该疾病的预防发生了重大转变。在因接种疫苗而对病毒产生免疫的人群中，宫颈癌的发病率下降了近 90%。 Peter Sasieni, a professor of cancer prevention at King's College London, says the screening programme needs to adapt soon. 英国伦敦国王学院的癌症预防教授彼得·萨西尼表示，宫颈癌检查项目需要尽快作出调整。 He told Inside Health on Radio 4 that current vaccines meant screening at ages 30, 40 and 55 could be appropriate, and that more effective vaccines being introduced this year could mean only one test a lifetime. 关于未来宫颈癌检查计划的走向，目前尚未有定论，而且疫苗的保护效果会持续多久，到中年后是否需要打加强针，这些仍是问题。另外，由于几代人都没有对 HPV 的免疫，所以在几十年间需要定期做检查。 词汇表 cases 病例 cervical cancer 宫颈癌 seismic 影响深远的，重大的 vaccine 疫苗 prevention 预防 screening 筛查，检查 effective 有效的 protection 保护 booster 加强针 阅读理解：请在读完上文后，回答下列问题。 1.

Cancer Screening Vaccine Cervical Hpv Cervical Cancer Needed Introduced Mean Fewer Peter Sasieni More Effective Vaccines  smear  cervical  vaccine  nearly  tests  hpv  introduced  vaccines  sasieni  适龄接种  疫苗可大幅减少患宫颈癌风险  mean  fewer  cancer  needed  screening

History of this topic

HPV screening may be added in national programme
8 months, 1 week ago

HPV screening may be added in national programme

Hindustan Times  

The Union health ministry is likely to incorporate HPV testing into the National Cancer Control Programme to screen women for cervical cancer, people familiar with the matter said. In India, the numbers are far higher, with cervical cancer being the second most form of cancer among women after breast cancer As part of the programme, the government is stepping up …

Homegrown solution to India's cervical cancer dilemma
8 months, 4 weeks ago

Homegrown solution to India's cervical cancer dilemma

Deccan Chronicle  

New Delhi, Mar 26 It's an almost entirely preventable disease but cervical cancer kills one woman in India every seven minutes. Launched in September 2022, India's first indigenously developed quadrivalent HPV vaccine, Cervavac, has the potential to improve access to vaccines and revolutionise cervical cancer prevention in these countries. As the global focus shifts towards eliminating cervical cancer as a …

Keep it wholesome: On shaping a national cervical cancer control programme
10 months ago

Keep it wholesome: On shaping a national cervical cancer control programme

The Hindu  

Health is seldom uni-dimensional, and it must not be seen as such. Union Finance Minister Nirmala Sitharaman’s announcement during the presentation of the interim Budget that the government plans to encourage vaccination against cervical cancer for girls aged nine to 14, is no doubt a step in the right direction. While the scheme will be fleshed out post elections, it …

Understanding cervical cancer and what is the HPV Vaccine
10 months, 1 week ago

Understanding cervical cancer and what is the HPV Vaccine

Hindustan Times  

The vaccine that protects people, especially women from the Human Papillomavirus infection has usually been quite expensive and hence not accessible for the majority of the population. HPV vaccine will be administered to girls aged 9 to 14 years Cervical cancer is a type of cancer that develops in the cervix, the lower part of the uterus that connects to …

Health Talk | Why vaccinating girls between 9 to 14 years against cervical cancer is vital
10 months, 2 weeks ago

Health Talk | Why vaccinating girls between 9 to 14 years against cervical cancer is vital

Hindustan Times  

Union finance minister Nirmala Sitharaman announced during her Budget speech on Thursday that the Centre planned to encourage cervical cancer vaccination for girls in the age group of 9 to 14 years. Experts said that vaccinating young girls is key to eliminating cervical cancer — one of the leading cancers in Indian women, and vaccine-preventable. “The results of the effectiveness …

The importance of periodic testing for Human Papillomavirus
11 months ago

The importance of periodic testing for Human Papillomavirus

The Hindu  

The New Year brings a whole host of resolutions. Now, says Dr. Gajaraj, HPV DNA testing is the recommended method for screening for cervical cancer: this involves testing cells from the cervix for infections with any of the HPV types that could cause cancer. The WHO, too, recommends that HPV DNA testing be the first-choice screening method for cervical cancer …

Cervical Cancer Deaths Can Be Reduced By Over 63 Per Cent Through Primary HPV Test Every 5 Years: Research
1 year ago

Cervical Cancer Deaths Can Be Reduced By Over 63 Per Cent Through Primary HPV Test Every 5 Years: Research

ABP News  

The implementation of updated screening guidelines by the World Health Organization can help reduce over 63 per cent of cervical cancer death rates in low-to-middle-income countries, new research led by the Daffodil Centre, a research centre on cancer control and policy, and a joint venture of Cancer Council NSW and the University of Sydney, has found. MUST READ | COP28: …

Watch | What is the Human Papillomavirus Virus vaccine?
1 year, 8 months ago

Watch | What is the Human Papillomavirus Virus vaccine?

The Hindu  

In December last year, the government of India announced that it will roll out the HPV vaccine, or the Human papillomavirus virus, for girls aged between 9 and 14 years. In India, one woman is killed every eight minutes due to cervical cancer. And even though cervical cancer is preventable, it kills 67,000 women per year in India alone. Even …

Serum Institute launches country’s first HPV vaccine against cervical cancer: Adar Poonawalla
1 year, 10 months ago

Serum Institute launches country’s first HPV vaccine against cervical cancer: Adar Poonawalla

Live Mint  

On the occasion of National Girl Child Day, the Serum Institute of India on Tuesday launched the first indigenously developed human papillomavirus vaccine -- “CERVAVAC,” against the cervical cancer in women. “On the occasion of India’s National Girl Child Day and Cervical Cancer Awareness Month, @SerumInstIndia is pleased to launch the first made-in-India HPV vaccine by the hands of our …

10 Facts You Need To Know About Human Papillomavirus Infection (HPV)
1 year, 11 months ago

10 Facts You Need To Know About Human Papillomavirus Infection (HPV)

News 18  

Cervical cancer is the second most common cancer of women in India, despite being largely preventable. India accounts for the highest number of cervical cancer cases as every year approximately 1.25 lakh women are diagnosed with cervical cancer, and over 75 thousand die from the disease in India. HPV 16 or 18 causes 83 percent of invasive cervical cancers and …

All That You Need To Know About HPV
1 year, 11 months ago

All That You Need To Know About HPV

ABP News  

New Delhi: Cervical cancer is the second most common cancer of women in India, despite being largely preventable. HPV 16 or 18 causes 83 percent of invasive cervical cancers and it takes 15-20 years from contracting the infection to developing cancer. The most effective prevention strategy for cervical cancer is the systematic screening of women along with treatment and HPV …

How to deal with cervical cancer in time
1 year, 11 months ago

How to deal with cervical cancer in time

Hindustan Times  

Cervical cancer has been a neglected cancer in India, in-spite of having a very effective screening method, which can be not only prevent the cervical cancer but can be eliminated by early diagnosis and treatment. Persistent of infection for at least for six months duration with high-risk HPV types is the first step in progression from HPV infection to cervical …

Cervical cancer dramatically rising in women over 30; expert on top reasons
2 years, 1 month ago

Cervical cancer dramatically rising in women over 30; expert on top reasons

Hindustan Times  

Cervical cancer cases among women in their eary 30s have dramatically increased in recent times, a study published in Journal of the American Medical Association said. Reasons why cervical cancer is on rise in women over 30 Dr Kapoor also opened up on reasons behind increases incidence of cervical cancer in women above 30. Multiple sex partners Dr Kapoor says …

Sierra Leone Introduces HPV Vaccine to Protect Girls from Cervical Cancer
2 years, 2 months ago

Sierra Leone Introduces HPV Vaccine to Protect Girls from Cervical Cancer

News 18  

The government of Sierra Leone has introduced the Human Papillomavirus vaccine to protect girls from cervical cancer, said a press statement by the Ministry of Health and Sanitation. MoHS said the HPV vaccine has provided a proven and safe tool to protect women and girls against the risk of cervical cancer and it is one of the key strategies that …

Why Serum Institute’s qHPV vaccine, India’s first against cervical cancer, is a game-changer
2 years, 3 months ago

Why Serum Institute’s qHPV vaccine, India’s first against cervical cancer, is a game-changer

Firstpost  

Cervavac, India’s first vaccine to fight cervical cancer, will be launched today. The country’s first ‘Made in India’ quadrivalent Human Papilloma Virus vaccine for the prevention of cervical cancer will be launched today. However, there is a risk for all women that HPV infection may become chronic and pre-cancerous lesions progress to invasive cervical cancer, says the WHO. According to …

九价HPV疫苗扩龄至9-45岁
2 years, 3 months ago

九价HPV疫苗扩龄至9-45岁

China Daily  

“默沙东中国”近日发布消息称，其九价人乳头瘤病毒疫苗（九价HPV疫苗）的新适应证已获得中国国家药品监督管理局批准，此次获批标志着默沙东九价HPV疫苗在国内适用人群拓展至9-45岁适龄女性。 A woman is inoculated with a cervical cancer vaccine in Jing'an county in Yichun, Jiangxi province on April 10, 2021. China's top drug regulator has expanded the use of an imported vaccine against nine strains of the cancer-causing human papillomavirus to girls as young as nine and adults up to age 45. 中国国家药品监督管理局近日批准将九价人乳头瘤病毒疫苗（九价HPV疫苗）在国内适用人群拓展至9-45岁适龄女性。 The National Medical Products Administration first …

九价HPV疫苗扩龄至9-45岁
2 years, 3 months ago

九价HPV疫苗扩龄至9-45岁

China Daily  

“默沙东中国”近日发布消息称，其九价人乳头瘤病毒疫苗（九价HPV疫苗）的新适应证已获得中国国家药品监督管理局批准，此次获批标志着默沙东九价HPV疫苗在国内适用人群拓展至9-45岁适龄女性。 A woman is inoculated with a cervical cancer vaccine in Jing'an county in Yichun, Jiangxi province on April 10, 2021. China's top drug regulator has expanded the use of an imported vaccine against nine strains of the cancer-causing human papillomavirus to girls as young as nine and adults up to age 45. 中国国家药品监督管理局近日批准将九价人乳头瘤病毒疫苗（九价HPV疫苗）在国内适用人群拓展至9-45岁适龄女性。 The National Medical Products Administration first …

Vaccine could mean fewer smear tests needed 适龄接种 HPV 疫苗可大幅减少患宫颈癌风险
2 years, 8 months ago

Vaccine could mean fewer smear tests needed 适龄接种 HPV 疫苗可大幅减少患宫颈癌风险

China Daily  

媒体英语 Vaccine could mean fewer smear tests needed 适龄接种 HPV 疫苗可大幅减少患宫颈癌风险 Play audio file 一位顶尖科学家表示，接种 HPV 疫苗的女性可能一生只需做一次刮片检查，就可以帮助预防宫颈癌。目前在英国，适龄女性每三到五年会被邀请进行一次筛查。 Nearly all cases of cervical cancer are caused by human papillomaviruses, known as HPV. 2008年，随着 HPV 疫苗（在英国）的引入，该疾病的预防发生了重大转变。在因接种疫苗而对病毒产生免疫的人群中，宫颈癌的发病率下降了近 90%。 Peter Sasieni, a professor of cancer prevention at King's College London, says the screening programme needs to adapt soon. 英国伦敦国王学院的癌症预防教授彼得·萨西尼表示，宫颈癌检查项目需要尽快作出调整。 He told Inside Health on …

US cervical cancers fall but other sex-related cancers rise
3 years, 7 months ago

US cervical cancers fall but other sex-related cancers rise

Associated Press  

Screening and the HPV vaccine have led to drops in cervical cancers over the last two decades in the U.S., a new study finds, but the gains are offset by a rise in other tumors caused by the virus. For older women, anal cancer and a rare type of rectal cancer caused by HPV may be more common than cervical …

Discover Related